We use cookies to enhance the usability of our website. If you continue, we'll assume that you are happy to receive all cookies. More information. Don't show this again.
The antibodies are designated mAB for monoclonal and pAb for polyclonal.
pAb
Concentration
Not known
Purity
Affinity
Released in versioni
The release of the Human Protein Atlas in which the antibody was first published.
19.0
Validation summaryi
All assays through which the antibody has been validated. Assays&annotation provide a detailed description of the different assays. The pie-charts indicate degree of validation.
Immunohistochemistry is used for validating antibody reliability by assessing staining pattern in 44 normal tissues. Validation scores include Enhanced, Supported, Approved and Uncertain.
Results of validation by standard or enhanced validation based on assessment of antibody performance in 44 normal tissues.
Standard validation results in scores Supported, Approved or Uncertain. An image representative of the antibody staining pattern is shown.
Enhanced validation results in the score Enhanced and includes two methods: Orthogonal validation and Independent antibody validation. For orthogonal validation, representative images of high and low expression are shown. For independent antibody validation, four images of each independent antibody are displayed.
SLC6A5 is highly enriched and displays moderate-intensity immunostaining of fine axonal networks in selected forebrain regions, such as the anterior and tuberal hypothalamus, lateral septum, BNST, certain thalamic nuclei and parts of amygdala. In the brainstem, widespread and general moderate-strong intensity immunostaining of axonal networks and synaptic fields is noticed. This protein distribution profile is in accordance with available RNA expression data and published literature. (Mouse brain)
The Human Protein Atlas project is funded
